Cardioloxía
Servicio
Borja
Ibáñez Cabeza
Publicacións nas que colabora con Borja Ibáñez Cabeza (41)
2024
-
Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)
European Journal of Heart Failure
-
Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial
Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460
2023
-
Bleeding and embolic risk in patients with atrial fibrillation and cancer
Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 344-352
-
Diferencias regionales en la atención al IAMCEST en España. Datos del Registro de Código Infarto ACI-SEC
REC: Interventional Cardiology, Vol. 5, Núm. 2, pp. 118-128
2022
-
Analysis of the management of ST-segment elevation myocardial infarction in Spain. Results from the ACI-SEC Infarction Code Registry
Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 669-680
-
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058
-
Nutrition status, obesity and outcomes in patients with atrial fibrillation
Revista Espanola de Cardiologia, Vol. 75, Núm. 10, pp. 826-833
-
Polypill Strategy in Secondary Cardiovascular Prevention
The New England journal of medicine, Vol. 387, Núm. 11, pp. 967-977
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
-
Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort
International Journal of Cardiology, Vol. 367, pp. 90-98
-
Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation
Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 334-342
2021
-
Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI)
Basic Research in Cardiology, Vol. 116, Núm. 1
-
Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes
Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791
-
In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients
EuroIntervention, Vol. 16, Núm. 17, pp. 1426-1433
-
Mitral valve prolapse morphofunctional features by cardiovascular magnetic resonance: more than just a valvular disease
Journal of Cardiovascular Magnetic Resonance, Vol. 23, Núm. 1
-
The Art of Prescribing β-Blockers After Myocardial Infarction
Circulation: Cardiovascular Interventions, Vol. 14, Núm. 4, pp. E010720
-
Triglycerides and Residual Atherosclerotic Risk
Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041